PD-L1 is commonly expressed and transcriptionally regulated by STAT3 and MYC in ALK-negative anaplastic large-cell lymphoma

被引:156
|
作者
Atsaves, V. [1 ]
Tsesmetzis, N. [1 ]
Chioureas, D. [1 ]
Kis, L. [1 ,2 ]
Leventaki, V. [3 ]
Drakos, E. [4 ]
Panaretakis, T. [1 ]
Grander, D. [1 ]
Medeiros, L. J. [5 ]
Young, K. H. [5 ]
Rassidakis, G. Z. [1 ,2 ,5 ]
机构
[1] Karolinska Inst, Canc Ctr Karolinska, Dept Oncol & Pathol, Stockholm, Sweden
[2] Karolinska Univ Hosp, Dept Pathol & Cytol, Stockholm, Sweden
[3] St Jude Childrens Res Hosp, Dept Pathol, 332 N Lauderdale St, Memphis, TN 38105 USA
[4] Univ Crete, Med Sch, Dept Pathol, Iraklion, Crete, Greece
[5] Univ Texas MD Anderson Canc Ctr, Dept Hematopathol, Houston, TX 77030 USA
关键词
KINASE; SURVIVAL; HODGKIN;
D O I
10.1038/leu.2017.103
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:1633 / 1637
页数:6
相关论文
共 50 条
  • [21] Small-cell pattern of DUSP22 rearranged ALK-negative anaplastic large-cell lymphoma with leukemic phase
    Aarakaki, Hideki
    Karube, Kennosuke
    BLOOD, 2022, 139 (03) : 465 - 465
  • [22] Rapid Fatal Pulmonary Complications in a Chinese Patient After Bortezomib Treatment for ALK-Negative Anaplastic Large-Cell Lymphoma
    Zhou, Xin
    Sun, Chao
    Wang, Jing
    Mao, Jingjue
    Guo, Hongfeng
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2010, 10 (02): : 152 - 154
  • [23] Jak3 contributes to the activation of ALK and Stat3 in ALK+ anaplastic large cell lymphoma
    Amin, HM
    Lin, Q
    Lai, R
    LABORATORY INVESTIGATION, 2006, 86 (04) : 417 - 419
  • [24] ALK-Negative Anaplastic Large Cell Lymphoma (ALCL): Prognostic Implications of Molecular Subtyping and JAK-STAT Pathway
    Parkhi, Mayur
    Bal, Amanjit
    Das, Ashim
    Kashyap, Dharambir
    Bhardwaj, Sandeep
    Prakash, Gaurav
    Malhotra, Pankaj
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2021, 29 (09) : 648 - 656
  • [25] Prognostic significance of CD56 expression for ALK-positive and ALK-negative anaplastic large-cell lymphoma of T/null cell phenotype
    Suzuki, R
    Kagami, Y
    Takeuchi, K
    Kami, M
    Okamoto, M
    Ichinohasama, R
    Mori, N
    Kojima, M
    Yoshino, T
    Yamabe, H
    Shiota, M
    Mori, S
    Ogura, M
    Hamajima, N
    Seto, M
    Suchi, T
    Morishima, Y
    Nakamura, S
    BLOOD, 2000, 96 (09) : 2993 - 3000
  • [26] Reply to "PD-L1 expression in anaplastic large cell lymphoma"
    Xu, Jie
    Li, Shaoying
    Medeiros, L. Jeffrey
    MODERN PATHOLOGY, 2020, 33 (06) : 1234 - 1235
  • [27] PD-L1 is Highly Expressed in ALK-Positive Large B-Cell Lymphoma
    Chen, Po-Han
    Yuan, Ji
    Zhang, Qian-Yun
    Wang, Huan-You
    Pan, Zenggang
    MODERN PATHOLOGY, 2020, 33 (SUPPL 2) : 1264 - 1265
  • [28] PD-L1 is Highly Expressed in ALK-Positive Large B-Cell Lymphoma
    Chen, Po-Han
    Yuan, Ji
    Zhang, Qian-Yun
    Wang, Huan-You
    Pan, Zenggang
    LABORATORY INVESTIGATION, 2020, 100 (SUPPL 1) : 1264 - 1265
  • [29] Clinicopathologic implication of PD-L1 and phosphorylated STAT3 expression in diffuse large B cell lymphoma
    Kwon, Hyun Jung
    Yang, Jeong Mi
    Lee, Jeong-Ok
    Lee, Jong Seok
    Paik, Jin Ho
    JOURNAL OF TRANSLATIONAL MEDICINE, 2018, 16
  • [30] Clinicopathologic implication of PD-L1 and phosphorylated STAT3 expression in diffuse large B cell lymphoma
    Hyun Jung Kwon
    Jeong Mi Yang
    Jeong-Ok Lee
    Jong Seok Lee
    Jin Ho Paik
    Journal of Translational Medicine, 16